Medical abortion offered in pharmacy versus clinic-based settings: A systematic review.


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
11 2021
Historique:
received: 03 06 2021
revised: 13 06 2021
accepted: 16 06 2021
pubmed: 28 6 2021
medline: 28 10 2021
entrez: 27 6 2021
Statut: ppublish

Résumé

Expanding access to medical abortion through pharmacies is a potential strategy to promote safe abortion care. To compare the effectiveness and safety of medical abortion offered in pharmacy settings with clinic-based medical abortion. We searched multiple databases and the gray literature through November 2020. No language restrictions were applied. We included randomized and nonrandomized comparative studies. We applied standard risk of bias tools to each included study and used GRADE methodology to assess certainty of evidence. The primary outcomes were completion of abortion without additional intervention, need for blood transfusion, and presence of uterine or systemic infection within 30 days of medical abortion. Our search yielded 2030 studies. One prospective cohort study from Nepal met inclusion criteria. This study collected data on 605 women obtaining medical abortion rom either a clinic or pharmacy, and was judged to have low risk of bias for our primary outcome. For women who received medical abortion in a pharmacy compared to a clinic there was probably little or no difference in complete abortion rates (adjusted risk difference 1.5%; 95% confidence interval [CI] -0.8 to 3.8, 1 study, 600 participants; low certainty of evidence). No cases of blood transfusion were reported in the study and a composite outcome comprised mainly of infection complications showed little or no difference between settings (adjusted risk difference 0.8; 95% CI -1.0 to 2.8, 1 study, 600 participants; very low certainty of evidence). Evidence from just one nonrandomized study provides low certainty evidence that the effectiveness of medical abortion is probably not different between the pharmacy or clinic setting. Provision of medical abortions through pharmacy-based models of care may improve access to safe abortion. Comparative studies examining each model of care and outcomes on safety, effectiveness, and patient experience are needed.

Identifiants

pubmed: 34175269
pii: S0010-7824(21)00213-4
doi: 10.1016/j.contraception.2021.06.014
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

478-483

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Maria I Rodriguez (MI)

Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, United States. Electronic address: rodrigma@ohsu.edu.

Alison B Edelman (AB)

Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, United States.

Alyssa Hersh (A)

Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, United States.

Pragya Gartoulla (P)

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

Jillian T Henderson (JT)

Kaiser Permanente, Center for Health Research, Portland, OR, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH